| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4789728
Max Phase: Preclinical
Molecular Formula: C23H31N3
Molecular Weight: 349.52
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCNCC1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32
Standard InChI: InChI=1S/C23H31N3/c1-3-12-24-16-17-15-23(4-2)11-7-13-25-14-10-19-18-8-5-6-9-20(18)26(17)21(19)22(23)25/h5-6,8-9,15,22,24H,3-4,7,10-14,16H2,1-2H3/t22-,23+/m1/s1
Standard InChI Key: UDZBQYUBEHIRMZ-PKTZIBPZSA-N
Associated Targets(non-human)
INS1(832/13) 136 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 349.52 | Molecular Weight (Monoisotopic): 349.2518 | AlogP: 4.58 | #Rotatable Bonds: 5 |
| Polar Surface Area: 20.20 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.58 | CX LogP: 4.06 | CX LogD: 1.73 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.80 | Np Likeness Score: 0.65 |
References
| 1. Wang J,Lv X,Xu J,Liu X,Du T,Sun G,Chen J,Shen X,Wang J,Hu L. (2020) Design, synthesis and biological evaluation of vincamine derivatives as potential pancreatic β-cells protective agents for the treatment of type 2 diabetes mellitus., 188 [PMID:31918073] [10.1016/j.ejmech.2019.111976] |
Source
Source(1):